Clinical Trials Logo

Clinical Trial Summary

Incidental affective states, i.e., affective states can influence decision making and selective attention to threatening information. Acute stress is such an affective state and is a powerful contextual modulator of decision-making processes and selective attention to threat. In terms of physiological and neurohormonal changes, the stress response has been well characterized: Exposure to stress elicits an array of autonomic, endocrine, and behavioral responses. The physiological stress response is mediated by the hypothalamic-pituitary-adrenal (HPA) axis and the locus coeruleus noradrenergic (LC-NA) system with cortisol and norepinephrine (NE) as their end products. There is compelling evidence that the stress hormones cortisol and NE influence cognitive processes. However, only very few studies so far used pharmacological approaches to specify the role of stress neuromodulators on decision making and selective attention to threat and these studies are hardly comparable due to differences in the experimental design, e.g., the decision making task used. Furthermore, the neural underpinnings of stress effects on decision making and selective attention to threat are uninvestigated so far. The aim of the proposed project is to clarify the role of the major stress neuromodulators, NE and cortisol, in their contribution to different processes related to decision making under risk and selective attention to threat. To this end, combined precise pharmacological stimulation, behavioral modeling, and fMRI methods will be applied to systematically disentangle the effects of stress hormones on risk attitudes and loss aversion as well as their relation to neural correlates of processing subjective value and risk. Using pharmacological manipulation, the influence of noradrenergic and glucocorticoid activity on decision making under risk at the behavioral, computational, and neural level will be investigated. In addition, the influence of noradrenergic and glucocorticoid activity on selective attention to threat at the behavioural and neural level using a dot-probe paradigm with fearful and neutral faces will be examined. Participants are randomly assigned to one of four groups: (A) yohimbine, (B) hydrocortisone, (C) yohimbine and hydrocortisone, or (D) placebo.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04359147
Study type Interventional
Source Charite University, Berlin, Germany
Contact
Status Completed
Phase N/A
Start date November 1, 2019
Completion date December 22, 2021

See also
  Status Clinical Trial Phase
Completed NCT04852315 - Acute Caffeine Ingestion on Futsal Performance N/A
Completed NCT05427409 - Ingestion of Beta-alanine Effects in Well-trained Tennis Players N/A
Completed NCT05425563 - Effects of Expectations on Negative Affect, Perceived Cognitive Effort, and Pain N/A
Recruiting NCT05007561 - Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences Early Phase 1
Recruiting NCT03897998 - Neural Correlates of Hypoalgesia Driven by Observation Phase 2
Recruiting NCT04851301 - Neural Mechanisms of Immersive Virtual Reality in Chronic Pain Phase 1/Phase 2
Recruiting NCT05145764 - Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl Phase 2
Completed NCT01167478 - Neurophysiological Reserve With Caffeine Manipulation N/A
Completed NCT05337527 - Neuromuscular Responses to Acute Beetroot Ingestion in Women Older Adults N/A
Terminated NCT01656577 - Pexacerfont for Stress-induced Food Craving Phase 0
Completed NCT04361968 - Combining Animal-assisted Intervention and Placebo-induced Analgesia N/A
Completed NCT03754062 - Pharmacological Modulation of Belief Salience Phase 1
Not yet recruiting NCT04317157 - Placebo Effects Investigated by Different Experimental Designs N/A
Completed NCT01361633 - The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly Phase 2
Completed NCT05209126 - Impact of Beetroot Juice Ingestion on Female Rugby Performance N/A
Completed NCT05521347 - Caffeine Supplementation Improves the Cognitive Abilities and Shooting Performance of Trained E-sports Players N/A
Completed NCT04975360 - Delayed-release Bedtime Caffeine and Sleep Inertia Symptoms Immediately Upon Awakening N/A
Completed NCT04671043 - Caffeine Ingestion to Counter the Exercise-mediated Fall in Glycaemia in Type 1 Diabetes N/A
Completed NCT01011465 - The Biology of Resilience N/A
Completed NCT05805540 - Effects on CK, RPE, VAS Scale and Physical Performance of Three Recovery Methods in Elite Basketball Players N/A